Sort
82,697 grants matching “vaccine development”
Mechanisms of repeated control of acute hepatitis C infection in humans
$781,044Andrea L Cox · Johns Hopkins University · U19 · FY2020 · AI
Antigen presentation by epithelial stem cells to promote life long immunity
$781,009Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2010 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$780,905Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Protective biomarkers for the development of vaccines against malaria
$780,873Philip Louis Felgner · Immport Therapeutics, Inc. · R44 · FY2013 · AI
Polymerase Inhibitors of Respiratory Syncytial Virus
$780,845Richard K. Plemper · Georgia State University · R01 · FY2021 · AI
Rational development of a vaccine against tick-borne rickettsioses
$780,835Rong Megan Fang · University Of Texas Med Br Galveston · R01 · FY2025 · AI
Carbohydrate based multi-component vaccine against Bordetella pertussis
$780,834Xuefei Huang · Michigan State University · R01 · FY2025 · AI
COVID-19 Serosurveys and Vaccine Study Site Preparations
$780,824Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
$780,790Charles M. Rice · Rockefeller University · R01 · FY2025 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$780,775Justin Richard Bailey · Johns Hopkins University · R01 · FY2025 · AI
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
$780,724Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2022 · AI
Clinical Studies on the Mechanisms of DF/DHF
$780,712Sharone Green · University Of Rhode Island · P01 · FY2012 · AI
Enterovirus interference with rotavirus vaccine replication and immunity
$780,668Megan T Baldridge · Washington University · R01 · FY2023 · AI
Core C - The University of Texas Medical Branch at Galveston
$780,615Thomas William Geisbert · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Understanding and optimizing antibody-based interventions against neonatal HSV infection
$780,611Margaret E Ackerman · Dartmouth College · R01 · FY2025 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$780,595David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Core-003
$780,573Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
$780,524Karen A Norris · University Of Georgia · R01 · FY2020 · AI
Immunoevasive Mucosal Vaccines Against HIV-1
$780,426Michael A Barry · Mayo Clinic Rochester · R01 · FY2016 · AI
Translational studies of hookworm infection in Ghana
$780,408Michael Cappello · Yale University · R01 · FY2025 · AI
Deriving correlates of protection from influenza-specific antibody and T cell receptor analysis.
$780,362Scott Dexter Boyd · Stanford University · U19 · FY2020 · AI
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
$780,309Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · CA
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
$780,295John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Broad spectrum inhibitors of paramyxovirus envelope proteins
$780,280Anne Moscona · Columbia University Health Sciences · R01 · FY2024 · AI
HIV-1 vaccine-elicited antibodies target envelope glycans
$780,235Kevin O Saunders · Duke University · R01 · FY2016 · AI